MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

MDT

97.25

+1.88%↑

VEEV

300.62

+4.11%↑

A

139.72

-0.04%↓

HQY

90.34

-0.32%↓

PHR.US

23.41

+5.4%↑

Search

Bruker Corp

Open

BrancheGesundheitswesen

36.24 3.78

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

34.39

Max

36.49

Schlüsselkennzahlen

By Trading Economics

Einkommen

-13M

4.2M

Verkäufe

-4M

797M

KGV

Branchendurchschnitt

59.385

35.739

Dividendenrendite

0.64

Gewinnspanne

0.527

Angestellte

11,396

EBITDA

-21M

68M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+28.34% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.64%

3.08%

Nächstes Ergebnis

4. Nov. 2025

Nächste Dividendenausschüttung

3. Okt. 2025

Nächstes Ex-Dividendendatum

1. Dez. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-551M

4.7B

Vorheriger Eröffnungskurs

32.46

Vorheriger Schlusskurs

36.24

Nachrichtenstimmung

By Acuity

9%

91%

7 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Bruker Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Sept. 2025, 22:10 UTC

Wichtige Markttreiber

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

Peer-Vergleich

Kursveränderung

Bruker Corp Prognose

Kursziel

By TipRanks

28.34% Vorteil

12-Monats-Prognose

Durchschnitt 44.56 USD  28.34%

Hoch 60 USD

Tief 38 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bruker Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

10 ratings

6

Buy

4

Halten

0

Sell

Technischer Score

By Trading Central

38.97 / 40.73Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

7 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
help-icon Live chat